CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis
Laine, Anni, Nagelli, Srikar G, Farrington, Caroline, Butt, Umar, Cvrljevic, Anna N, Vainonen, Julia P, Feringa, Femke M, Grönroos, Tove J, Gautam, Prson, Khan, Sofia, Sihto, Harri, Qiao, Xi, Pavic, Karolina, Connolly, Denise C, Kronqvist, Pauliina, Elo, Laura L, Maurer, Jochen, Wennerberg, Krister, Medema, Rene H, Joensuu, Heikki, Peuhu, Emilia, de Visser, Karin, Narla, Goutham, Westermarck, Jukka
Published in Cancer research (Chicago, Ill.) (15.08.2021)
Published in Cancer research (Chicago, Ill.) (15.08.2021)
Get full text
Journal Article
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Mäkelä, Eleonora, Pavic, Karolina, Varila, Taru, Salmenniemi, Urpu, Löyttyniemi, Eliisa, Nagelli, Srikar G, Ammunét, Tea, Kähäri, Veli-Matti, Clark, Richard E, Elo, Laura L, Bachanaboyina, Venkata Kumari, Lucas, Claire M, Itälä-Remes, Maija, Westermarck, Jukka
Published in Clinical cancer research (15.05.2021)
Published in Clinical cancer research (15.05.2021)
Get full text
Journal Article
Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model
Pattni, Bhushan S., Nagelli, Srikar G., Aryasomayajula, Bhawani, Deshpande, Pranali P., Kulkarni, Abhijit, Hartner, William C., Thakur, Ganesh, Degterev, Alexei, Torchilin, Vladimir P.
Published in Pharmaceutical research (01.10.2016)
Published in Pharmaceutical research (01.10.2016)
Get full text
Journal Article
Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model
Pattni, Bhushan S., Nagelli, Srikar G., Aryasomayajula, Bhawani, Deshpande, Pranali P., Kulkarni, Abhijit, Hartner, William C., Thakur, Ganesh, Degterev, Alexei, Torchilin, Vladimir P.
Published in Pharmaceutical research (01.11.2016)
Published in Pharmaceutical research (01.11.2016)
Get full text
Journal Article